Imaging Solutions In the Imaging Solutions segment, consolidated revenue amounted to ¥332.6 billion (down 14.0% from the previous fiscal year). Launching new products was partly postponed until the fiscal year ending March 2021 due to the spread of COVID-19 epidemic, causing our group factories in China to postpone the restart of operations by extending the […]
Fujifilm to Develop AI-based Technology to Aid COVID-19-Induced Pneumonia Diagnosis and Assess The Effectiveness of Treatments Company commences joint research study with leading medical institutions in Japan, applying lesion quantification technology for pneumonia TOKYO, May 19, 2020 — FUJIFILM Corporation (President: Kenji Sukeno) is commencing a research study to develop Artificial Intelligence (AI)-based technology to […]
We have been following Fujifilm Avigan (Favipiravir) and COVID-19 involvement for a while ( 1, 2, 3, 4, 5, 6, 7, 8, 9, 10. 11, 12, 13) and trials keep coming up with positive results. It is now being reported that Fujifilm is sharing their “wonder drug” via the Japanese Government with 43 countries for approval in the treatments of COVID-19 via the United Nations Office for […]
Translated Notification of application of public medical insurance to the new gene detection kit “SARS-CoV-2 RT-qPCR Detection kit” for coronavirus that greatly shortens PCR test time (Fujifilm Wako Pure Chemical) FUJIFILM Wako Pure Chemical Industries, Ltd. (Head office: Chuo-ku, Osaka, President: Kazuo Shiraki) has announced that the research reagent “SARS-CoV-2 RT-qPCR Detection kit” released on April 15 […]
FUJIFILM Diosynth Biotechnologies teams with COVID-19 Therapeutics Accelerator to reserve manufacturing capacity and provide technical expertise to deliver future COVID-19 therapies HILLERØD, Denmark, April 30, 2020 – FUJIFILM Diosynth Biotechnologies, a world leading biologics-Contract Development and Manufacturing Organization (CDMO), today announced that it will reserve manufacturing capacity for a future COVID-19 therapy for the COVID-19 […]
Notice of the Postponement of Announcement of Financial Results (Consolidated) for the Fiscal Year ended March 31, 2020 FUJIFILM Holdings Corporation (the “Company”) would like to express our deepest sympathy to all those who lost loved ones and those affected by COVID-19. Since it will take more time than we expected to close consolidated financial […]
